US Healthcare Could Be the Booster Shot That “Healthy China” Needs
Published: | Updated:
The Chinese government's “Healthy China” plan presents an unprecedented opportunity for the US healthcare industry and its investors, writes Steven Shill.
Steven Shill
Advertisement
Steven Shill is an assurance partner and national co-leader of The BDO Center for Healthcare Excellence & Innovation. He can be reached at sshill@bdo.com.
Articles by Steven Shill
Advertisement
Latest Updated Articles
- US Healthcare Could Be the Booster Shot That “Healthy China” Needs
Published: December 1st 2017 | Updated: November 15th 2020
Advertisement
Advertisement
Trending on PharmExec
1
The Influence of Trump Rx in Pharmacy Benefit Managers, Retail Pharmacies, and Digital Health Platforms
2
Bringing HIV Prevention DTC: Q&A with Ashley Gildea
3
FDA Approves Hernexeos Under National Priority Voucher Program
4
Leading in the Psychedelic Space: Q&A with Tarek Rabah
5